CD4+ T cells expressing IL-10 and chimeric antigen receptors and uses thereof
Grant
US12576150B2
Kind: B2
Mar 17, 2026
Assignee
Tr1x, Inc.
Inventors
Jan Egbert De Vries, Maria Grazia Roncarolo, Xavier Paliard, David De Vries
Abstract
The present disclosure provides a population of CD4IL-10/CAR cells (autologous or allogeneic single-donor and allogeneic polydonor) generated by genetically modifying CD4+ T cells to express IL-10 and a chimeric antigen receptor. Further provided are methods of generating the CD4IL-10/CAR cells and methods of using the CD4IL-10/CAR cells for immune tolerization, treating GvHD, cell and organ transplantation, cancer, and other autoimmune and inflammatory disorders.
CPC Classifications
A61K 38/2066
A61K 40/31
C07K 14/5428
C07K 14/7051
Filing Date
2025-02-26
Application No.
19064325
Claims
5